Microbes as medicine
Annals of the New York Academy of Sciences · 2024-11 · 1541 (1) · 63-82
DOI: 10.1111/nyas.15237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, online erschienen am 11.10.2024. Verfasst von Brendan A Daisley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Probiotics, Microbiota. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canada Research Chairs, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Over the last two decades, advancements in sequencing technologies have significantly deepened our understanding of the human microbiome's complexity, leading to increased concerns about the detrimental effects of antibiotics on these intricate microbial ecosystems. Concurrently, the rise in antimicrobial resistance has intensified the focus on how beneficial microbes can be harnessed to treat diseases and improve health and offer potentially promising alternatives to traditional antibiotic treatments. Here, we provide a comprehensive overview of both established and emerging microbe‐centric therapies, from probiotics to advanced microbial ecosystem therapeutics, examine the sophisticated ways in which microbes are used medicinally, and consider their impacts on microbiome homeostasis and health outcomes through a microbial ecology lens. In addition, we explore the concept of rewilding the human microbiome by reintroducing “missing microbes” from nonindustrialized societies and personalizing microbiome modulation to fit individual microbial profiles—highlighting several promising directions for future research. Ultimately, the advancements in sequencing technologies combined with innovative microbial therapies and personalized approaches herald a new era in medicine poised to address antibiotic resistance and improve health outcomes through targeted microbiome management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
ORCID-Profile: Emma Allen-Vercoe
Förderung
- Canada Research Chairs
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Daisley, B. A., & Allen-Vercoe, E. (2024). Microbes as medicine. Annals of the New York Academy of Sciences, 1541(1), 63-82. https://doi.org/10.1111/nyas.15237
Vancouver
Daisley BA, Allen-Vercoe E. Microbes as medicine. Annals of the New York Academy of Sciences. 2024;1541(1):63-82. doi:10.1111/nyas.15237
BibTeX
@article{Daisley2024,
author = {Daisley, Brendan A and Allen-Vercoe, Emma},
title = {Microbes as medicine},
journal = {Annals of the New York Academy of Sciences},
year = {2024},
volume = {1541},
number = {1},
pages = {63--82},
doi = {10.1111/nyas.15237}
}
EUVIMED